tiprankstipranks
Restart Life Sciences (NMLSF)
OTHER OTC:NMLSF
US Market
NMLSF
Restart Life Sciences
RESEARCH TOOLSreports
Want to see NMLSF full AI Analyst Report?

Restart Life Sciences (NMLSF) Income Statement

31 Followers

Restart Life Sciences Income Statement

Last quarter (Q4 2025), Restart Life Sciences's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q4, Restart Life Sciences's net income was C$-157.32K. See Restart Life Sciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Mar 25Mar 24Mar 23Mar 22
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ 0.00C$ 0.00C$ 25.41KC$ -3.79KC$ -5.00K
Operating Expenses
C$ 1.35MC$ 658.51KC$ 1.26MC$ 1.94MC$ 2.93M
Depreciation and Amortization
C$ 1.85KC$ 2.31KC$ 2.94KC$ 3.79KC$ 5.00K
EBITDA
C$ -1.34MC$ -656.20KC$ -1.20MC$ -1.84MC$ -2.68M
Operating Income
C$ -1.35MC$ -658.51KC$ -1.23MC$ -1.94MC$ -2.93M
Other Income/Expenses
C$ -45.22KC$ 883.26KC$ 7.74KC$ -527.00KC$ 249.46K
Pretax Income
C$ -1.39MC$ 224.75KC$ -1.22MC$ -2.47MC$ -2.68M
Net Income
C$ -1.39MC$ 224.75KC$ -1.22MC$ -3.76MC$ -2.68M
Per Share Metrics
Basic EPS
C$ -0.04C$ 0.01C$ -0.01C$ -0.02C$ -0.02
Diluted EPS
C$ -0.04C$ 0.01C$ -0.01C$ -0.02C$ -0.02
Weighted Average Shares Outstanding
 33.90M 15.29M 146.78M 136.56M 111.10M
Weighted Average Shares Outstanding (Diluted)
 33.90M 16.11M 146.76M 136.56M 111.10M
Currency in CAD

Restart Life Sciences Earnings and Revenue History